Europe Generic Drug Market Report by Segment (Unbranded Generics, Branded Generics), Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail, Hospital), and Country 2024-2032

<p>The Europe generic drug market size reached US$ 61.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 110.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. The growing prevalence of chronic ailments, such as diabetes and cardiovascular diseases, advancements in drug formulation techniques including fixed-dose combinations and economically viable treatment options and the development and approval of biosimilars are among the key factors driving the market growth.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left">Report Attribute&nbsp;</div>
</th>
<th scope="col">
<div style="text-align:left">Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>
<div>2023</div>
</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2024-2032</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td>
<div><strong>Market Size in 2023</strong></div>
</td>
<td>US$ 61.1&nbsp;Billion</td>
</tr>
<tr>
<td>
<div><strong>Market Forecast in 2032</strong></div>
</td>
<td>US$ 110.8 Billion</td>
</tr>
<tr>
<td><strong>Market Growth Rate (2024-2032)</strong></td>
<td>6.6%</td>
</tr>
</tbody>
</table>

<p>IMARC Group provides an analysis of the key trends in each segment of the Europe generic drug market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on segment, therapy area, drug delivery, and distribution channel.</p>

欧洲通用药物市场规模于2023年达到611亿美元。展望未来，IMARC集团预计，该市场规模将于2032年增至1108亿美元，在2024至2032年期间展现出6.6%的复合年增长率。慢性疾病（如糖尿病和心血管疾病）的日益普遍、药物制剂技术的进步，包括固定剂量组合以及经济可行的治疗方案，以及生物类似物的研发和批准，均是推动市场增长的关键因素。